(ACOMO) Amsterdam Commodities - Ratings and Ratios
Exchange: AS •
Country: Netherlands •
Currency: EUR •
Type: Common Stock •
ISIN: NL0000313286
Spices, Nuts, Seeds, Tea, Organic
| Risk via 10d forecast | |
|---|---|
| Volatility | 17.3% |
| Value at Risk 5%th | 24.9% |
| Relative Tail Risk | -12.78% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.57 |
| Alpha | 36.57 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.408 |
| Beta | 0.028 |
| Beta Downside | 0.147 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.26% |
| Mean DD | 10.57% |
| Median DD | 11.92% |
Description: ACOMO Amsterdam Commodities October 24, 2025
Acomo N.V. (ticker ACOMO) is a Rotterdam-based global trader and processor of food ingredients, operating across five segments: Spices & Nuts, Edible Seeds, Organic Ingredients, Tea, and Food Solutions. The company sources, packages, and distributes both conventional and organic commodities to food-and-beverage manufacturers in the Netherlands, broader Europe, North America, and other international markets.
Key industry data that contextualise Acomo’s positioning include: (1) the global spices market is projected to grow at a CAGR of roughly 5 % through 2029, driven by rising consumer interest in ethnic cuisines and premium flavours; (2) organic ingredient sales are expanding at an estimated 8 % annual rate, reflecting heightened demand for clean-label products and regulatory incentives in Europe and the U.S.; and (3) Acomo’s 2023 revenue was approximately €1.2 billion with an EBITDA margin near 6 %, a modest but stable profitability profile given the commodity-price volatility that typifies the sector.
If you want a data-rich, scenario-based assessment of ACOMO’s valuation and risk factors, the ValueRay platform provides a transparent toolkit that can help you extend this initial analysis.
ACOMO Stock Overview
| Market Cap in USD | 817m |
| Sub-Industry | Food Distributors |
| IPO / Inception | |
| Return 12m vs S&P 500 | 24.2% |
| Analyst Rating | - |
ACOMO Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 5.59% |
| Yield on Cost 5y | 7.86% |
| Yield CAGR 5y | 1.12% |
| Payout Consistency | 83.9% |
| Payout Ratio | 55.6% |
ACOMO Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 13.57% |
| CAGR/Max DD Calmar Ratio | 0.56 |
| CAGR/Mean DD Pain Ratio | 1.28 |
| Current Volume | 18.8k |
| Average Volume | 26.3k |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (45.2m TTM) > 0 and > 6% of Revenue (6% = 81.8m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA -14.64pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 21.50% (prev 22.36%; Δ -0.85pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 30.7m <= Net Income 45.2m (YES >=105%, WARN >=100%) |
| Net Debt (272.8m) to EBITDA (97.5m) ratio: 2.80 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.90 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (29.6m) change vs 12m ago 0.74% (target <= -2.0% for YES) |
| Gross Margin 14.47% (prev 13.97%; Δ 0.50pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 165.0% (prev 164.8%; Δ 0.21pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.16 (EBITDA TTM 97.5m / Interest Expense TTM 19.2m) >= 6 (WARN >= 3) |
Altman Z'' 4.19
| (A) 0.33 = (Total Current Assets 620.3m - Total Current Liabilities 327.3m) / Total Assets 883.4m |
| (B) 0.26 = Retained Earnings (Balance) 229.2m / Total Assets 883.4m |
| (C) 0.10 = EBIT TTM 79.7m / Avg Total Assets 825.7m |
| (D) 0.49 = Book Value of Equity 229.2m / Total Liabilities 466.7m |
| Total Rating: 4.19 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 54.03
| 1. Piotroski 3.50pt |
| 2. FCF Yield 2.41% |
| 3. FCF Margin 1.69% |
| 4. Debt/Equity 0.62 |
| 5. Debt/Ebitda 2.80 |
| 6. ROIC - WACC (= 3.41)% |
| 7. RoE 10.84% |
| 8. Rev. Trend -34.42% |
| 9. EPS Trend 9.40% |
What is the price of ACOMO shares?
As of November 21, 2025, the stock is trading at EUR 23.25 with a total of 18,824 shares traded.
Over the past week, the price has changed by -2.31%, over one month by -6.63%, over three months by +3.10% and over the past year by +38.93%.
Over the past week, the price has changed by -2.31%, over one month by -6.63%, over three months by +3.10% and over the past year by +38.93%.
Is ACOMO a buy, sell or hold?
Amsterdam Commodities has no consensus analysts rating.
What are the forecasts/targets for the ACOMO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26 | 11.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 26.5 | 13.9% |
ACOMO Fundamental Data Overview November 18, 2025
Market Cap USD = 816.9m (705.1m EUR * 1.1586 EUR.USD)
Market Cap EUR = 705.1m (705.1m EUR * 1.0 EUR.EUR)
P/E Trailing = 9.9786
P/E Forward = 10.8108
P/S = 0.4852
P/B = 1.6688
Beta = 0.26
Revenue TTM = 1.36b EUR
EBIT TTM = 79.7m EUR
EBITDA TTM = 97.5m EUR
Long Term Debt = 108.5m EUR (from longTermDebt, last quarter)
Short Term Debt = 167.4m EUR (from shortLongTermDebt, last quarter)
Debt = 255.1m EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 272.8m EUR (from netDebt column, last quarter)
Enterprise Value = 957.1m EUR (705.1m + Debt 255.1m - CCE 3.05m)
Interest Coverage Ratio = 4.16 (Ebit TTM 79.7m / Interest Expense TTM 19.2m)
FCF Yield = 2.41% (FCF TTM 23.0m / Enterprise Value 957.1m)
FCF Margin = 1.69% (FCF TTM 23.0m / Revenue TTM 1.36b)
Net Margin = 3.32% (Net Income TTM 45.2m / Revenue TTM 1.36b)
Gross Margin = 14.47% ((Revenue TTM 1.36b - Cost of Revenue TTM 1.17b) / Revenue TTM)
Gross Margin QoQ = none% (prev 15.62%)
Tobins Q-Ratio = 1.08 (Enterprise Value 957.1m / Total Assets 883.4m)
Interest Expense / Debt = 4.27% (Interest Expense 10.9m / Debt 255.1m)
Taxrate = 25.50% (15.4m / 60.6m)
NOPAT = 59.4m (EBIT 79.7m * (1 - 25.50%))
Current Ratio = 1.90 (Total Current Assets 620.3m / Total Current Liabilities 327.3m)
Debt / Equity = 0.62 (Debt 255.1m / totalStockholderEquity, last quarter 414.5m)
Debt / EBITDA = 2.80 (Net Debt 272.8m / EBITDA 97.5m)
Debt / FCF = 11.84 (Net Debt 272.8m / FCF TTM 23.0m)
Total Stockholder Equity = 417.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.12% (Net Income 45.2m / Total Assets 883.4m)
RoE = 10.84% (Net Income TTM 45.2m / Total Stockholder Equity 417.3m)
RoCE = 15.16% (EBIT 79.7m / Capital Employed (Equity 417.3m + L.T.Debt 108.5m))
RoIC = 8.75% (NOPAT 59.4m / Invested Capital 678.7m)
WACC = 5.34% (E(705.1m)/V(960.2m) * Re(6.12%) + D(255.1m)/V(960.2m) * Rd(4.27%) * (1-Tc(0.26)))
Discount Rate = 6.12% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 81.65 | Cagr: 0.01%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈66.8m ; Y1≈82.4m ; Y5≈140.7m
Fair Price DCF = 80.76 (DCF Value 2.39b / Shares Outstanding 29.6m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 9.40 | EPS CAGR: 311.4% | SUE: 0.0 | # QB: 0
Revenue Correlation: -34.42 | Revenue CAGR: -1.94% | SUE: 0.15 | # QB: 0
Market Cap EUR = 705.1m (705.1m EUR * 1.0 EUR.EUR)
P/E Trailing = 9.9786
P/E Forward = 10.8108
P/S = 0.4852
P/B = 1.6688
Beta = 0.26
Revenue TTM = 1.36b EUR
EBIT TTM = 79.7m EUR
EBITDA TTM = 97.5m EUR
Long Term Debt = 108.5m EUR (from longTermDebt, last quarter)
Short Term Debt = 167.4m EUR (from shortLongTermDebt, last quarter)
Debt = 255.1m EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 272.8m EUR (from netDebt column, last quarter)
Enterprise Value = 957.1m EUR (705.1m + Debt 255.1m - CCE 3.05m)
Interest Coverage Ratio = 4.16 (Ebit TTM 79.7m / Interest Expense TTM 19.2m)
FCF Yield = 2.41% (FCF TTM 23.0m / Enterprise Value 957.1m)
FCF Margin = 1.69% (FCF TTM 23.0m / Revenue TTM 1.36b)
Net Margin = 3.32% (Net Income TTM 45.2m / Revenue TTM 1.36b)
Gross Margin = 14.47% ((Revenue TTM 1.36b - Cost of Revenue TTM 1.17b) / Revenue TTM)
Gross Margin QoQ = none% (prev 15.62%)
Tobins Q-Ratio = 1.08 (Enterprise Value 957.1m / Total Assets 883.4m)
Interest Expense / Debt = 4.27% (Interest Expense 10.9m / Debt 255.1m)
Taxrate = 25.50% (15.4m / 60.6m)
NOPAT = 59.4m (EBIT 79.7m * (1 - 25.50%))
Current Ratio = 1.90 (Total Current Assets 620.3m / Total Current Liabilities 327.3m)
Debt / Equity = 0.62 (Debt 255.1m / totalStockholderEquity, last quarter 414.5m)
Debt / EBITDA = 2.80 (Net Debt 272.8m / EBITDA 97.5m)
Debt / FCF = 11.84 (Net Debt 272.8m / FCF TTM 23.0m)
Total Stockholder Equity = 417.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.12% (Net Income 45.2m / Total Assets 883.4m)
RoE = 10.84% (Net Income TTM 45.2m / Total Stockholder Equity 417.3m)
RoCE = 15.16% (EBIT 79.7m / Capital Employed (Equity 417.3m + L.T.Debt 108.5m))
RoIC = 8.75% (NOPAT 59.4m / Invested Capital 678.7m)
WACC = 5.34% (E(705.1m)/V(960.2m) * Re(6.12%) + D(255.1m)/V(960.2m) * Rd(4.27%) * (1-Tc(0.26)))
Discount Rate = 6.12% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 81.65 | Cagr: 0.01%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈66.8m ; Y1≈82.4m ; Y5≈140.7m
Fair Price DCF = 80.76 (DCF Value 2.39b / Shares Outstanding 29.6m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 9.40 | EPS CAGR: 311.4% | SUE: 0.0 | # QB: 0
Revenue Correlation: -34.42 | Revenue CAGR: -1.94% | SUE: 0.15 | # QB: 0